genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2021
Adenosine receptor
Cancer
Immunotherapies Expose and Exploit Cancer’s Varied Weaknesses
News
Mixed mRNA Tails Less Easily Docked
Drug Discovery
Inspyr, Lewis and Clark Merge with Prodrug and Adenosine Receptor Modulator Pipeline
Drug Discovery
Merck KGaA, Domain to Develop Adenosine Receptor Inhibitors for Immuno-Oncology
News
Shire Licenses Heptares’ Adenosine A
2A
Receptor Antagonist for CNS Diseases
News
Can-Fite Spins Out Ophthalmology Activities to Israel-Based Subsidiary of U.S. Firm Denali
News
Structure of Critical GPCR Determined
News
CV Therapeutics Earns $10M Milestone from TPG-Axon Capital
News
NovaCardia Raises $48 M in Series B
Scroll Up
Scroll Up
